DaVita
Headquarters as seen from the Denver Millennium Bridge | |
| Type | Public |
|---|---|
| Industry | Healthcare |
| Founded | 1992 |
| Headquarters | Denver, Colorado, U.S. |
| Key people | Javier J. Rodriguez (CEO) |
| Services | Kidney dialysis |
| Revenue | |
| Total assets | |
| Total equity | |
| Owner | Berkshire Hathaway (41.2%) |
Number of employees | 78,000 (2025) |
| Website | davita |
| Footnotes | |
DaVita Inc. (a shortened contraction of "dare vita, meaning "to give life" in the Italian language) is an American health care company, incorporated in Delaware and headquartered in Denver, that provides kidney dialysis services through a network of 2,657 outpatient centers in the United States. DaVita serves 200,500 patients (36% of the total of 557,000 patients in the U.S.), and has 585 outpatient centers in 14 other countries serving 94,500 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo kidney dialysis, often 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation.
In 2025, 68% of the company's revenues came from Medicare and other government-based health insurance programs. In 2025, 89% of the company's patients were covered by government-based health insurance programs. Commercial payers, which accounted for 32% of revenues in 2025, generate nearly all of the company's profit as they reimburse at a much higher rate than government-based health insurance programs. The company is ranked 331st on the 2026 Fortune 500.